AVY vs REGN · P/E 17, rev $8.76B vs P/E 14, rev $14.34B
Avery Dennison Corp (AVY) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Avery Dennison Corp (AVY) is a packaging & containers company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AVY revenue for 2024-12-28 was $8.76B. Net income was $704.9M. Revenue was up 4.7% from 2023-12-30 to 2024-12-28. AVY currently screens at market cap $11.87B and trailing P/E 17.5.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AVY currently screens at market cap $11.87B and trailing P/E 17.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AVY and REGN stock pages for the full models.
Not investment advice.